SI3220946T1 - Sestave in metode za lajšanje in preprečevanje vnetja črevesja zaradi prisotnosti antigenov peptidnih živil v črevesu - Google Patents

Sestave in metode za lajšanje in preprečevanje vnetja črevesja zaradi prisotnosti antigenov peptidnih živil v črevesu

Info

Publication number
SI3220946T1
SI3220946T1 SI201531696T SI201531696T SI3220946T1 SI 3220946 T1 SI3220946 T1 SI 3220946T1 SI 201531696 T SI201531696 T SI 201531696T SI 201531696 T SI201531696 T SI 201531696T SI 3220946 T1 SI3220946 T1 SI 3220946T1
Authority
SI
Slovenia
Prior art keywords
intestine
relieving
compositions
methods
intestinal inflammation
Prior art date
Application number
SI201531696T
Other languages
English (en)
Slovenian (sl)
Inventor
David Schriemer
Martial Rey
Original Assignee
Codexis, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Codexis, Inc. filed Critical Codexis, Inc.
Publication of SI3220946T1 publication Critical patent/SI3220946T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/488—Aspartic endopeptidases (3.4.23), e.g. pepsin, chymosin, renin, cathepsin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/23—Aspartic endopeptidases (3.4.23)
    • C12Y304/23012—Nepenthesin (3.4.23.12)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
SI201531696T 2014-06-16 2015-06-16 Sestave in metode za lajšanje in preprečevanje vnetja črevesja zaradi prisotnosti antigenov peptidnih živil v črevesu SI3220946T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201462012865P 2014-06-16 2014-06-16
US201562118396P 2015-02-19 2015-02-19
PCT/CA2015/000389 WO2015192211A1 (en) 2014-06-16 2015-06-16 Compositions and methods for treating gluten intolerance and disorders arising therefrom
EP15809878.0A EP3220946B1 (en) 2014-06-16 2015-06-16 Compositions and methods for attenuating and preventing intestinal inflammation due to the presence of peptidic food antigens in an intestine

Publications (1)

Publication Number Publication Date
SI3220946T1 true SI3220946T1 (sl) 2021-11-30

Family

ID=54934596

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201531696T SI3220946T1 (sl) 2014-06-16 2015-06-16 Sestave in metode za lajšanje in preprečevanje vnetja črevesja zaradi prisotnosti antigenov peptidnih živil v črevesu

Country Status (8)

Country Link
US (3) US20160022785A1 (enExample)
EP (2) EP3943104A1 (enExample)
JP (2) JP6829077B2 (enExample)
CN (2) CN113827708A (enExample)
DK (1) DK3220946T3 (enExample)
ES (1) ES2883347T3 (enExample)
SI (1) SI3220946T1 (enExample)
WO (1) WO2015192211A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160022785A1 (en) 2014-06-16 2016-01-28 Nepetx, Llc Compositions and methods for treating gluten intolerance and disorders arising therefrom
JP2019504011A (ja) 2015-12-16 2019-02-14 ネプエトゥクス，エルエルシー グルテン不耐症およびそれにより発生する障害を治療するための組成物および方法
CN108504615B (zh) * 2018-03-30 2020-12-29 江南大学 一种产酸性蛋白酶的重组菌及其应用
EP4522200A2 (en) * 2022-05-10 2025-03-19 Codexis, Inc. Recombinant neprosin polypeptides and methods of expression
CN115336666A (zh) * 2022-07-05 2022-11-15 熊子奕 猪笼草捕虫囊蛋白酶降低乳清蛋白致敏性的应用及方法

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK81193D0 (da) 1993-07-06 1993-07-06 Novo Nordisk As Enzym
JP3767831B2 (ja) 1995-06-14 2006-04-19 木村 健 ヘリコバクター・ピロリ除菌用組成物
JPH1149697A (ja) 1997-08-01 1999-02-23 Nisshin Flour Milling Co Ltd ストレス抑制剤及びストレス抑制用食品
DE19980245D2 (de) 1998-02-23 2001-05-10 Keller Helmut Verwendung eines Preßsaftes, Verdauungssaftes oder Extraktes von fleischfressenden Pflanzen zur Hemmung von Proteinkinasen
FI980410A0 (fi) 1998-02-23 1998-02-23 Tapio Raivio Termoset
US7169175B2 (en) 2000-05-22 2007-01-30 Orbusneich Medical, Inc. Self-expanding stent
ATE505201T1 (de) 2002-02-14 2011-04-15 Univ Leland Stanford Junior Enzymbehandlung von nahrungsmitteln für zöliakie- sprue
US7320788B2 (en) * 2002-02-14 2008-01-22 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for Celiac Sprue
US8143210B2 (en) 2002-02-14 2012-03-27 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
JP4415244B2 (ja) 2003-02-21 2010-02-17 グリコ栄養食品株式会社 小麦蛋白質にプロテアーゼを限定的に作用させて得られる食品素材
US7122035B2 (en) 2003-11-13 2006-10-17 Jerome Canady Bipolar surgical forceps with argon plasma coagulation capability
CN100384442C (zh) * 2004-01-13 2008-04-30 吴琼汉 一种中草药制剂及其制备方法和应用
US7628985B2 (en) 2004-04-26 2009-12-08 The Board Of Regents Of The Leland Stanford Junior University Therapeutic enzyme formulations and uses thereof in celiac sprue and/or dermatitis herpetoformis
US20060095096A1 (en) 2004-09-09 2006-05-04 Debenedictis Leonard C Interchangeable tips for medical laser treatments and methods for using same
EP1856291A4 (en) 2005-03-04 2009-04-01 Verenium Corp NUCLEIC ACIDS AND PROTEINS, AND METHODS OF MAKING AND USING SAME
EP1949093A2 (en) 2005-10-11 2008-07-30 Alvine Pharmaceuticals, Inc. Compositions and methods for enhanced gastrointestinal stability of oligopeptides and polypeptides
AU2007299219A1 (en) 2006-04-05 2008-03-27 Metanomics Gmbh Process for the production of a fine chemical
US20080115411A1 (en) 2006-11-16 2008-05-22 Ramsey Philip W Weed control system
US7645977B2 (en) 2006-11-17 2010-01-12 New Visual Media Group, L.L.C. Low cost dynamic insulated glazing unit
CN101627098B (zh) 2006-12-04 2013-04-24 三菱瓦斯化学株式会社 含有甲醛系聚合物的树脂材料的粘接方法以及结构体
WO2008115428A2 (en) 2007-03-16 2008-09-25 The Board Of Trustees Of The Leland Stanford Junior University A scaleable manufacturing process for cysteine endoprotease b, isoform 2
EP2136833B1 (en) 2007-03-16 2019-05-01 The Board of Trustees of the Leland Stanford Junior University Combination enzyme therapy for digestion of dietary gluten
EP2229404A4 (en) 2007-12-10 2011-03-09 Univ Leland Stanford Junior ENZYMATIC POLYTHERAPY FOR GASTRIC DIGESTION OF FOOD GLUTEN IN PATIENTS WITH CELIAC DISEASE
EP2100900A1 (en) 2008-03-07 2009-09-16 Universitätsspital Basel Bombesin analog peptide antagonist conjugates
AU2009283157B2 (en) 2008-08-21 2015-02-26 Alvine Pharmaceuticals, Inc. Formulation for oral administration of proteins
EP2344183B1 (en) 2008-10-10 2015-02-25 Alvine Pharmaceuticals, Inc. Dosage forms that facilitate rapid activation of zymogen
CN101732504A (zh) * 2010-01-06 2010-06-16 宋晓翠 猪笼草和艾蒿、香蒲草制成的妇科药物及其制备方法
EP2531521B1 (en) 2010-02-02 2017-09-06 Amano Enzyme USA., Ltd. Use of proteases for gluten intolerance
EP2555792A4 (en) 2010-03-30 2013-11-06 Alvine Pharmaceuticals Inc PROTEASES DEGRADING GLUTEN
US9598684B2 (en) 2010-07-07 2017-03-21 Trustees Of Boston University Rothia species gluten-degrading enzymes and uses thereof
US9023345B2 (en) 2011-03-01 2015-05-05 Novus International, Inc. Methods for improving gut health
WO2012145369A1 (en) * 2011-04-22 2012-10-26 Faerstein Paul Joseph Compositions and methods for nutritional supplementation
US9005610B2 (en) 2012-11-21 2015-04-14 Nepetx, Llc Treatment of gluten intolerance and related conditions
US8837173B2 (en) 2013-01-02 2014-09-16 Chicony Power Technology Co., Ltd DC to DC power converting device
WO2014116871A1 (en) 2013-01-23 2014-07-31 Alvine Pharmaceuticals, Inc. Methods and pharmaceutical compositions for treating celiac disease and gluten intolerance
US20160022785A1 (en) 2014-06-16 2016-01-28 Nepetx, Llc Compositions and methods for treating gluten intolerance and disorders arising therefrom
JP2019504011A (ja) 2015-12-16 2019-02-14 ネプエトゥクス，エルエルシー グルテン不耐症およびそれにより発生する障害を治療するための組成物および方法

Also Published As

Publication number Publication date
DK3220946T3 (da) 2021-08-02
EP3220946A1 (en) 2017-09-27
JP7369893B2 (ja) 2023-10-27
US10960059B2 (en) 2021-03-30
JP2017519763A (ja) 2017-07-20
EP3943104A1 (en) 2022-01-26
US20210220451A1 (en) 2021-07-22
EP3220946A4 (en) 2018-08-15
JP6829077B2 (ja) 2021-02-10
WO2015192211A1 (en) 2015-12-23
CN106794228B (zh) 2021-09-03
US20160022785A1 (en) 2016-01-28
US20190022194A1 (en) 2019-01-24
ES2883347T3 (es) 2021-12-07
WO2015192211A9 (en) 2016-02-25
CN106794228A (zh) 2017-05-31
CN113827708A (zh) 2021-12-24
EP3220946B1 (en) 2021-06-09
US11723960B2 (en) 2023-08-15
JP2021073236A (ja) 2021-05-13

Similar Documents

Publication Publication Date Title
IL251834A0 (en) Pharmaceutical compositions containing peptide variants and methods of using them
IL252026B (en) Humanized anti-complement factor c1q antibodies and uses thereof
DK3145493T3 (da) Fremgangsmåder og sammensætninger vedrørende exosomer
SI2943078T1 (sl) Metode in sestava izdelkov za zaužitje
MA40595A (fr) Récepteurs chimériques et utilisations de ceux-ci en thérapie immunitaire
IL255307B (en) Tpp1 formulations and uses thereon in cln2 disease
PL3189074T3 (pl) Kompozycje oraz sposoby leczenia i zapobiegania zapaleniom
SI3800177T1 (sl) Sestavki fenfluramina in njihovi načini priprave
DK3240436T3 (da) Sammensætning indeholdende kitin og fordøjelige proteiner
IL280690A (en) Pharmaceutical preparations that include DGLA and their use
DK3209307T3 (da) Probiotiske og præbiotiske sammensætninger
BR112016016338A2 (pt) Produto alimentício e método de preparação
IL261777B (en) Palatable compositions including sodium phenylbutyrate and uses thereof
PL3364777T3 (pl) Konserwacja witamin rozpuszczalnych w wodzie
EP3253395C0 (en) PROBIOTIC PREPARATION FOR THE TREATMENT OF INTESTINAL INFLAMMATION
SI3220946T1 (sl) Sestave in metode za lajšanje in preprečevanje vnetja črevesja zaradi prisotnosti antigenov peptidnih živil v črevesu
PL3444349T3 (pl) Sposoby i kompozycje do zapobiegania urazom niedokrwienno-reperfuzyjnym w narządach
IL246711A0 (en) Biologically active haloperoxidase compositions and methods of using them
IL252779A0 (en) Prevention and treatment of inflammatory conditions
IL252070A0 (en) Preparations containing apoequrin and methods of using them to treat neuritis
FR3022461B1 (fr) Methodes therapeutiques et compositions
PL3191080T3 (pl) Kompozycje pozajelitowe i ich zastosowanie
TH1501007169A (th) เบต้า-คาเซอิน a2 และการป้องกันการอักเสบของลำไส้
TH1501005510A (th) องค์ประกอบ และวิธีการของการส่งเสริมการตอบสนองของภูมิคุ้มกัน ต่อเชื้อโรคในลำไส้
SMP201400077B1 (it) Composizione fitoterapica ed integratore alimentare contenente detta composizione fitoterapica